Literature DB >> 21149804

Kinesigenic dyskinesia in a case of voltage-gated potassium channel-complex protein antibody encephalitis.

Enrique Aradillas1, Robert J Schwartzman.   

Abstract

OBJECTIVE: To describe the first case (to our knowledge) of voltage-gated potassium channel-complex protein antibody encephalitis with kinesigenic dyskinesia and cramp-fasciculation syndrome.
DESIGN: Case report.
SETTING: Hospitalized care. PATIENT: A 38-year-old man with a history of bronchial asthma, eczema, vitiligo, and immune complex mesangiopathic glomerulonephritis presented with abnormal movements. MAIN OUTCOME MEASURES: Clinical examination, magnetic resonance imaging, single-photon emission computed tomography, electromyography and nerve conduction studies, video-electroencephalographic monitoring, plasmapheresis exchange therapy, and intravenous immunoglobulin administration.
RESULTS: Clinical examination revealed paroxysmal kinesigenic dyskinesia and fasciculations. Magnetic resonance imaging of the brain revealed a left caudate and left putamen increased signal lesion on T2-weighted and fluid-attenuated inversion recovery sequences as well as increased flow in the same region on single-photon emission computed tomographic scans. Electromyography and nerve conduction studies revealed significant afterdischarges, cramp potentials, and continuous motor activity. The video-electroencephalographic monitoring revealed no epileptiform discharges. The patient dramatically improved after 5 plasmapheresis exchange treatments and a course of intravenous immunoglobulin at 2 gm/kg over 5 divided doses.
CONCLUSION: To our knowledge, this is the first report of paroxysmal kinesigenic dyskinesia with voltage-gated potassium channel-complex protein antibody encephalitis associated with the cramp fasciculation syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21149804     DOI: 10.1001/archneurol.2010.317

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

Review 1.  Episodic movement disorders: from phenotype to genotype and back.

Authors:  Knut Brockmann
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

2.  Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures.

Authors:  Eoin P Flanagan; Amy L Kotsenas; Jeffrey W Britton; Andrew McKeon; Robert E Watson; Christopher J Klein; Bradley F Boeve; Val Lowe; J Eric Ahlskog; Cheolsu Shin; Christopher J Boes; Brian A Crum; Ruple S Laughlin; Sean J Pittock
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-10-01

3.  Faciobrachial dystonic seizures result from fronto-temporo-basalganglial network involvement.

Authors:  Rajesh Shankar Iyer; T C R Ramakrishnan; Ajit Shinto; Koramadai Karuppuswamy Kamaleshwaran
Journal:  Epilepsy Behav Case Rep       Date:  2017-06-08

Review 4.  Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questions.

Authors:  Ochuko D Bakpa; Markus Reuber; Sarosh R Irani
Journal:  Seizure       Date:  2016-07-15       Impact factor: 3.184

5.  Immunotherapy by targeting of VGKC complex for seizure control and prevention of cognitive impairment in a mouse model of epilepsy.

Authors:  Zhiliang Fan; Xiaojuan Feng; Zhigang Fan; Xingyuan Zhu; Shaohua Yin
Journal:  Mol Med Rep       Date:  2018-05-09       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.